Oxford Medical Diagnostics

oxford medical diagnostics develops breath analysis technologies for rapid, accurate, and low-cost monitoring of diseases and metabolic functions. using it's cavity enhanced absorption spectroscopy (ceas) technology, the company has developed a compact, portable sensor for the detection of breath acetone which is a direct marker of circulating blood ketone levels. this technology will be applied in 2 key areas: 1. diabetes healthcare: uncontrolled diabetes can lead to elevated blood ketone levels and to a condition known as diabetic ketoacidosis (dka); a potentially fatal condition and the main cause of mortality in type 1 diabetics. oxford medical diagnostics aims to develop an early warning breath test, primarily for type 1 diabetics, to prevent the onset of dka and mitigate hospitalisations and associated costs. 2. the wellness market: obesity is a huge economic burden attributed to some £47bn of uk economy. weight-loss programmes aimed to reduce obesity levels often suffer from hig